Christine Digregorio
Adult Health · Worcester, MANPI 1497892293
Payments from drug & device makers
Across 131 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$740
- AstraZeneca$418
- Novo Nordisk$288
- Boehringer Ingelheim$250
- Pfizer$133
- Bayer$102
- plus $884 from 20 others
What the payments were for
- Food & beverage$2,815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 31 | $740 |
| AstraZeneca | 23 | $418 |
| Novo Nordisk | 13 | $288 |
| Boehringer Ingelheim | 12 | $250 |
| Pfizer | 7 | $133 |
| Bayer | 2 | $102 |
| E.r. Squibb & Sons, L.L.C. | 4 | $98 |
| Merck | 5 | $91 |
| Abbott | 4 | $84 |
| Daiichi Sankyo Inc. | 4 | $73 |
| Johnson & Johnson | 3 | $70 |
| Exact Sciences | 3 | $66 |
| Ardelyx, Inc. | 2 | $52 |
| GSK | 2 | $39 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Novartis | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Amgen | 2 | $30 |
| Pulmonx Corporation | 1 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| AbbVie | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
How this compares
$2,815 in reported general payments places this provider in the 90th percentile of 671 adult health providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $22,472 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,621 |
| Atorvastatin Calcium | 129 | $1,372 |
| Levothyroxine Sodium | 68 | $899 |
| Divalproex Sodium | 13 | $892 |
| Omeprazole | 50 | $657 |
| Klor-Con 10Potassium Chloride | 12 | $580 |
| Metoprolol Succinate | 29 | $541 |
| Lisinopril | 80 | $538 |
| Fenofibrate | 14 | $480 |
| Amlodipine Besylate | 50 | $388 |
| Ibuprofen | 30 | $377 |
| Nystatin | 14 | $339 |
| Simvastatin | 37 | $322 |
| Gabapentin | 13 | $269 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $288 | $22,47220 claims |
| AstraZenecaSymbicort | $418 | $2,62112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 671 adult health providers in Massachusetts.
Other adult health in Worcester
- Emerentia AgyemangWorcester$420K
- Jill TerrienWorcester$18K
- Jeanne SnowWorcester$6K
- Krista TuckerBoston$157K
- Kathleen Dietz LovettHyannis$123K
- Caitlin ReenCharlestown$89K
- Tiffini ReedyFall River$58K
- Cynthia HarringtonBoston$39K
- Christine AgiusBoston$32K
- Amy PierreJamaica Plain$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.